Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the timeline of recovery for patients with cataract undergoing corrective surgery.
Recovery from cataract surgery typically allows patients to still function and be able to complete light tasks in the first week, with patients able to resume normal schedules after this time, said Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson (J&J) Vision.
Transcript
For employers considering coverage of cataract surgery in their health plan, can you speak on the procedure’s recovery time?
Fortunately, cataract surgery is a relatively rapid recovery. It's outpatient surgery done under anesthesia that is topical, often with a mild sedative for the patient. And they can typically, by the next day, be able to still function and do daily activities with light, strenuous range, because they can still function with their other eye even while they're healing.
Usually it's just a day or 2 of down time, but then we ask patients to take it easy for the first week or so and then they're pretty much back to normal. Most commonly, patients will have surgery on each eye a week or two apart.
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More